Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Study of cytokine-induced immunity in bullous pemphigoid: recent developments. | Ann Med | 2023 | 38109924 | PubTator, text mining | PubMed |
| Harnessing immunotherapy for brain metastases: insights into tumor-brain microenvironment interactions and emerging treatment modalities. | J Hematol Oncol | 2023 | 38104104 | PubTator, text mining | PubMed |
| Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project. | Orphanet J Rare Dis | 2023 | 38102667 | PubTator, text mining | PubMed |
| Wild-type S100A3 and S100A13 restore calcium homeostasis and mitigate mitochondrial dysregulation in pulmonary fibrosis patient-derived cells. | Front Cell Dev Biol | 2023 | 38099297 | PubTator, text mining | PubMed |
| Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus. | Front Immunol | 2023 | 38098483 | PubTator, text mining | PubMed |
| Menahydroquinone-4 may play a key role in regulating CCL5 expression induced by epidermal growth factor receptor inhibitors. | Sci Rep | 2023 | 38092882 | PubTator, text mining | PubMed |
| Overexpression of Dock180 and Elmo1 in Melanoma is Associated with Cell Survival and Migration. | Ann Dermatol | 2023 | 38086358 | PubTator, text mining | PubMed |
| Latent inter-organ mechanism of idiopathic pulmonary fibrosis unveiled by a generative computational approach. | Sci Rep | 2023 | 38081956 | PubTator, text mining | PubMed |
| A two-sample Mendelian randomization analysis: causal association between chemokines and pan-carcinoma. | Front Genet | 2023 | 38075694 | PubTator, text mining | PubMed |
| Cellular Responses to Extracellular Vesicles as Potential Markers of Colorectal Cancer Progression. | Int J Mol Sci | 2023 | 38069076 | PubTator, text mining | PubMed |
| Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma. | Cancers (Basel) | 2023 | 38067341 | PubTator, text mining | PubMed |
| Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 38067251 | PubTator, text mining | PubMed |
| Spatial Transcriptomics Reveals Signatures of Histopathological Changes in Muscular Sarcoidosis. | Cells | 2023 | 38067175 | PubTator, text mining | PubMed |
| Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8. | Nat Commun | 2023 | 38040762 | PubTator, text mining | PubMed |
| Anti-inflammatory mechanisms in cancer research: Characterization of a distinct M2-like macrophage model derived from the THP-1 cell line. | Cancer Med | 2023 | 38037545 | PubTator, text mining | PubMed |
| Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease. | J Neuroinflammation | 2023 | 38037070 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: an effective player of the tumor microenvironment. | Front Immunol | 2023 | 38035101 | PubTator, text mining | PubMed |
| The cross-talk between macrophages and tumor cells as a target for cancer treatment. | Front Oncol | 2023 | 38033495 | PubTator, text mining | PubMed |
| PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. | Nat Commun | 2023 | 38030622 | PubTator, text mining | PubMed |
| Changes in eotaxin-3 and pulmonary and activation-regulated chemokine levels in patients after dupilumab treatment: a systematic review and meta-analysis. | Postepy Dermatol Alergol | 2023 | 38028411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=18